Clinical Research1-Year Outcome of TRIAS HR (TRI-Stent Adjudication Study–High Risk of Restenosis): A Multicenter, Randomized Trial Comparing Genous Endothelial Progenitor Cell Capturing Stents With Drug-Eluting Stents
Under an Elsevier user license
open archive
Key Words
drug-eluting stent(s)
endothelial progenitor cell capturing stent(s)
endothelialization
restenosis
Abbreviations and Acronyms
CI
confidence interval
DSMB
data and safety monitoring board
eCRF
electronic case report form
ECS
endothelial progenitor cell capturing stent(s)
EES
everolimus-eluting stent(s)
EPC
endothelial progenitor cell
MI
myocardial infarction
PCI
percutaneous coronary intervention
PES
paclitaxel-eluting stent(s)
SES
sirolimus-eluting stent(s)
SMC
smooth muscle cell
ST
stent thrombosis
TLF
target lesion failure
TLR
target lesion revascularization
TVF
target vessel failure
TVR
target vessel revascularization
ZES
zotarolimus-eluting stent(s)
Cited by (0)
This investigator-initiated study was in part funded by OrbusNeich by means of an unrestricted educational grant. All authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.